Author: Yoshimura, Yukihiro; Sasaki, Hiroaki; Horiuchi, Hiroshi; Miyata, Nobuyuki; Tachikawa, Natsuo
Title: Clinical characteristics of the coronavirus disease 2019 (COVID-19) outbreak on a cruise ship Cord-id: uwvgl44j Document date: 2020_6_12
ID: uwvgl44j
Snippet: BACKGROUND: A large COVID-19 outbreak occurred on the cruise ship Diamond Princess in February 2020. Little information has been reported about the clinical characteristics of the patients. METHODS: This single-center, retrospective, observational study was conducted in Yokohama, Japan. We included symptomatic patients who were infected on the ship and admitted to our hospital between 5 and 19 February 2020. All the cases were confirmed with SARS-CoV-2 infection by polymerase chain reaction (PCR
Document: BACKGROUND: A large COVID-19 outbreak occurred on the cruise ship Diamond Princess in February 2020. Little information has been reported about the clinical characteristics of the patients. METHODS: This single-center, retrospective, observational study was conducted in Yokohama, Japan. We included symptomatic patients who were infected on the ship and admitted to our hospital between 5 and 19 February 2020. All the cases were confirmed with SARS-CoV-2 infection by polymerase chain reaction (PCR). RESULTS: We confirmed 17 cases. The average age was 69 years; 10 patients were Asian and 7 were Caucasian. Eleven patients had one or more chronic diseases. The major symptoms were cough and fever. Chest computed tomography (CT) scans found bilateral ground-glass opacities predominantly in the peripheral area, which were similar to reports from cases in China. C-reactive protein (CRP) levels were higher in severe and critical cases than in mild to moderate cases. The moderate to severe cases reached symptomatic resolution; one of the three critical cases resulted in death due to multiple organ failure. SARS-CoV-2 was detected by PCR at an average of 7 days after symptomatic resolution. CONCLUSIONS: Cough and fever, increased blood CRP levels, and CT findings of bilateral ground-glass opacities predominantly in the peripheral lung were characteristic of the COVID-19 cases in this study. These findings were compatible with those of previous reports.
Search related documents:
Co phrase search for related documents- absolute lymphocyte count and lopinavir ritonavir: 1
- absolute lymphocyte count and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- absolute lymphocyte count and lymphocyte number: 1, 2
- absolute lymphocyte count and lymphocyte percentage: 1, 2, 3, 4, 5, 6
- absolute lymphocyte number and lymphocyte count: 1
- absolute lymphocyte number and lymphocyte number: 1, 2, 3, 4, 5, 6, 7
- absolute lymphocyte number and lymphocyte percentage: 1, 2, 3, 4
- admission blood test and lopinavir ritonavir: 1
- admission blood test and lymphocyte count: 1, 2
- admission oxygen therapy and lopinavir ritonavir: 1, 2
- admission oxygen therapy and lymphocyte count: 1, 2, 3, 4
- admission oxygen therapy and lymphocyte percentage: 1, 2
- admission oxygen therapy need and lymphocyte count: 1
- admission symptom onset and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8
- long period and lymphocyte count: 1, 2
- lopinavir ritonavir and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Co phrase search for related documents, hyperlinks ordered by date